Part of the Law Commons
Antitrust and the Biopharmaceutical Industry: Lessons from Hatch-Waxman and an Early Evaluation of the Biologics Price Competition and Innovation Act of 2009, Matthew J. Seamon Nova Law Review
PDF
Advanced Search